Dr. Catherine Stehman-Breen discusses her career journey, from her early interest in medicine to her roles at pharmaceutical companies like Amgen. The highlight is her time as CEO of Chroma Medicine, a biotech focused on epigenetic editing.
Follow us on https://signal.nucleate.xyz/
04:14 - Dr. Stehman-Breen discusses her decision to pursue a career in medicine.
05:49 - Dr. Stehman-Breen explains her specialty choice in internal medicine and nephrology.
08:09 - Skills and mindset that prepared Catherine for a career in industry.
13:53 - The critical impact that physicians can have in biotech
19:03 - Overview of epigenetic editing and Chroma Medicine's approach.
0:28:22 - Early days of building Chroma Medicine from the ground up.
0:38:22 - Merger with NVelop Therapeutics and future directions.
0:44:22 - Dr. Stehman-Breen offers advice for entrepreneurs and the value of an Entrepreneur in Residence role.
0:49:22 - Balancing her demanding career with personal hobbies and interests.